Trial site
Haaglanden Medisch Centrum
- 11running trials
- 4closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Deep vein thrombosis and pulmonary embolism2 trials
- Aortic aneurysm1 trial
- Atrial fibrillation1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- COPD1 trial
- Coronary artery disease1 trial
- Gastric and oesophageal cancer1 trial
- Glioblastoma1 trial
- Heart failure1 trial
- Kidney cancer1 trial
- Lung cancer1 trial
- and 4 more
- Phase
- Phase 32 trials
- Phase 42 trials
- Phase 21 trial
- Status
- Recruiting5 trials
- Active, not recruiting3 trials
- Completed3 trials
- Not yet recruiting2 trials
- Enrolling by invitation1 trial
- Terminated1 trial
- Lead sponsor
- Leiden University Medical Center2 trials
- Radboud University Medical Center2 trials
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1 trial
- Amsterdam UMC, location VUmc1 trial
- Borstkanker Onderzoek Groep1 trial
- and 8 more
Running trials
Not yet recruiting
Endoscopic (EID) Versus Surgical (TAMIS) Local Excision for Early Stage Rectal Cancer
Recruiting
Recruiting
Recruiting
Recruiting
The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients
Recruiting
Recruiting
National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
Active, not recruiting
Enrolling by invitation
The NetherLands Registry of Invasive Coronary Vasomotor Function Testing (NL-CFT)
Active, not recruiting
Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Colorectal cancer1 recruiting
- COPD1 recruiting
- Coronary artery disease1 recruiting
- Kidney cancer1 recruiting
- Lung cancer1 recruiting
- Melanoma1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026